 NEW YORK and VIENNA, Austria, Jan. 04, 2022 GLOBE NEWSWIRE -- HOOKIPA Pharma Inc. NASDAQ: HOOK, HOOKIPA, a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Company will present at the virtual H.C. Wainwright BioConnect Conference, January 10 - 13, 2022. The presentation will be available beginning at 7:00 AM EST on Monday, January 10. 